A single dose, randomized, blinded, bioequivalence study of tibolone tablets in a 2 way crossover comparison against the innovator tibolone tablet conducted under fasting conditions in healthy female volunteers
Phase of Trial: Phase I
Latest Information Update: 24 Jun 2016
Price : $35 *
At a glance
- Drugs Tibolone (Primary)
- Indications Menopausal syndrome
- Focus Pharmacokinetics
- Sponsors Zenith Technology Corporation
- 24 Jun 2016 Last checked against Australian New Zealand Clinical Trials Registry record.
- 10 Oct 2014 Status changed from not yet recruiting to completed as reported by Australian New Zealand Clinical Trials Registry.
- 31 Jul 2013 New trial record